CPTx

Planegg, Germany

CPTx develops single-stranded DNA products to neutralize viruses and address infectious diseases.

$29.0M raised

Sep 2024

Venture - Series Unknown

Top Investors

BlueYard CapitalBayern KapitalLeblon CapitalSPRIN-DMarius Nacht

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has CPTx raised?

CPTx has raised $29.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2024.

Who are CPTx's investors?

CPTx's investors include BlueYard Capital, Bayern Kapital, Leblon Capital, SPRIN-D, Marius Nacht.

Where is CPTx headquartered?

CPTx is headquartered in Planegg, Germany.

What does CPTx do?

CPTx develops single-stranded DNA products to neutralize viruses and address infectious diseases.

What stage is CPTx at?

CPTx is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 12, 2024.

MLA

"CPTx — Funding & Investors." VCBacked, September 12, 2024, https://www.vcbacked.co/company/cptx. Accessed June 4, 2026.

APA

VCBacked. (2024). CPTx — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/cptx

Wikipedia (cite web)

{{cite web |title=CPTx — Funding & Investors |url=https://www.vcbacked.co/company/cptx |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 12, 2024.